EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSDCDG00000003148
Gene Symbol: KCNQ5
3 Cross references
200 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSDCDG00000030966
Gene Symbol: PSENEN
3 Cross references
185 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSDCDG00000031795
Gene Symbol: LOC114788018
3 Cross references
202 Possible Orthologues:

Presenilin-2-Like

Ensembl ID : ENSDCDG00000021405
Gene Symbol: LOC114785753
3 Cross references
206 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSDCDG00000027370
Gene Symbol: LOC114794112
3 Cross references
413 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSDCDG00000034288
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSDCDG00000033955
Gene Symbol: LOC114767894
2 Cross references
205 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSDCDG00000025606
Gene Symbol: PTGDR2
3 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSDCDG00000030746
Gene Symbol: PTGER2
3 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSDCDG00000034969
Gene Symbol: PTGER3
3 Cross references
197 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSDCDG00000026283
Gene Symbol: LOC114786863
3 Cross references
171 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSDCDG00000014656
Gene Symbol: LOC114793460
3 Cross references
163 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).